LOUISBOURG INVESTMENTS INC.

Position in NTLA — Intellia Therapeutics, Inc.

CIK 2053050 DIEPPE, A3

Position in NTLA

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$3,384

+$820 QoQ

Shares Held

200

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#290

of 327 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOUISBOURG INVESTMENTS INC. holds $41,332 across 5 Biotechnology names. NTLA ranks #3 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	502	$28,147
2	CRSP	CRISPR Therapeutics AG	80	$4,363
3	NTLA	Intellia Therapeutics, Inc. This page	200	$3,384
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6	$2,980
5	RXRX	Recursion Pharmaceuticals, Inc.	670	$2,458

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,384	200	0.0%	Shares	Sole	2026-07-23
2026-03-31	$2,564	200	0.0%	Shares	Sole	2026-04-22
2025-12-31	$1,798	200	—	Shares	Sole	2026-01-16
No filing history on record for this holder in this stock.